Dr. Anthony Atala is the Director of the Wake Forest Institute for Regenerative Medicine. He is a practicing surgeon and a researcher in the area of regenerative medicine. His work focuses on growing human cells, tissues and organs.
Dr. Atala works with several journals and serves in various roles, including Editor-in-Chief of: Stem Cells- Translational Medicine; Therapeutic Advances in Urology; and BioPrinting. Dr. Atala was elected to the Institute of Medicine of the National Academy of Sciences in 2011, to the National Academy of Inventors as a Charter Fellow in 2013, and to the American Institute for Medical and Biological Engineering in 2016. Dr. Atala is a recipient of various awards, including the US Congress funded Christopher Columbus Foundation Award, bestowed on a living American who is currently working on a discovery that will significantly affect society, the World Technology Award in Health and Medicine, presented to individuals achieving significant and lasting progress, the Edison Science/Medical Award, the 2016 Smithsonian Ingenuity Award, the R&D 2016 Innovator of the Year Award, and the Fast Company 2017 World Changing Ideas Award for Bioprinting Tissue and Organs.
Dr. Atala’s work has been described in the lay press and was listed as Time Magazine’s top 5 medical breakthroughs of the year in 2007 and 2011, and as one of 5 discoveries that will change the future of organ transplants in 2013. He was named by Scientific American as one of the world’s most influential people in biotechnology in 2015, by U.S. News & World Report as one of 14 Pioneers of Medical Progress in the 21st Century, and by the American Association of Retired Persons as one of the 50 influential people who will make life better. In 2017 Dr. Atala was named by Life Sciences Intellectual Property Review as one of 50 key influencers in the life sciences intellectual property arena, and by Nature Biotechnology as one of the top 20 translational researchers in the world.
Dr. Atala has led or served several national professional and government committees, including the National Institutes of Health working group on Cells and Developmental Biology, the National Institutes of Health Bioengineering Consortium, and the National Cancer Institute’s Advisory Board, and was the Founder of the Regenerative Medicine Foundation. Dr. Atala heads a team of over 450 researchers and physicians. Over 14 applications of technologies developed in Dr. Atala's laboratory have been used clinically. He is the editor of 20 books, including Principles of Regenerative Medicine, 3D Biofabrication, Essentials of Stem Cell Biology, and Methods of Tissue Engineering. He has published more than 600 journal articles and has applied for or received over 250 national and international patents.